Align Technology | ALGN - Equity Capital And Reserves


Align Technology reported $3.96B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
3M USD 4.75B 119M Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Cardinal Health USD -2.88B 5M Dec/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
CVS Health USD 75.21B 2.29B Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Dexcom USD 2.75B 19.9M Dec/2025
Henry Schein USD 3.24B 116M Dec/2025
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Masimo USD 810M 232.8M Sep/2025
McKesson USD -1.3B 441M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
Stryker USD 21.78B 594M Sep/2025
Teleflex USD 3.82B 421M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Veeva Systems USD 7.04B 402.09M Sep/2025
Waters USD 2.56B 230.55M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025